Togo - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Togo Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases grew 22.7% year on year. With 25 Cases in 2019, the country was number 215 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Togo is overtaken by Australia, which was number 214 with 26 Cases and is followed by Syria at 24 Cases. India ranked the highest with 66,255 Cases in 2019, that is an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 25.00 |
| 2018 | 24.00 |
| 2017 | 27.00 |
| 2016 | 11.00 |
| 2015 | 8.00 |
How does Togo rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 212 |
#212
Eritrea
|
27 | 2019 | +3.9 % | +4.2 % | View data | |
| 215 |
#215
Togo
|
25 | 2019 | +4.2 % | +22.7 % | View data | |
| 216 |
#216
Syria
|
24 | 2019 | +9.1 % | -5.0 % | View data | |